Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome
Not Applicable
- Conditions
- Acute coronary syndrome
- Registration Number
- JPRN-UMIN000002742
- Lead Sponsor
- Department of Cardiology, Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
1) Known hypersensitivity to the study drugs 2) Triglycerides >= 400 mg/dL 3) Concurrent serious liver disease* or renal disease** *: Apparent hepatic disorder with AST or ALT >3-fold the institutional ULN **: Treatment with dialysis or serum creatinine level >3.0 mg/dL 4) Diagnosis of malignant tumor 5) Pregnant or lactating women or women who may be pregnant 6) Familial hypercholesterolemia 7) Percutaneous coronary intervention (PCI) within the past 6 months or coronary artery bypass grafting (CABG) within the past 2 months 8) Current treatment with cyclosporine 9) Other conditions that, in the opinion of the investigator, would render the patient unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method